Novo Nordisk A/S stock price
NVO
#63

₺1.828,29
  

0.12%

Novo Nordisk A/S Info

Piyasa değ.
₺8,1T

0.12%

Günlük Hacim
₺33,79B
Varlık türü
Hisse S.
Çalışanlar
78387
Kuruluş
Dec 21, 1923
Temel borsa
New York Stock Exchange
CIK numarası
0000353278

Tokenize Hisse Verileri

Ort. Tokenize Fiyat
₺1,82K
Fiyat Farkı
+₺6,18(-0.34%)
Tokenize Piy. Değ.
₺148,09M

3.8%

Tokenize Hac. (24s)
₺37,92M

4.14%

İhraççı
Sözleşmeler
Gezginler
NVO/USD Dönüştürücü
NVO
TRY
Fiyat performansı
Düşük
₺1,75K
Yüksek
₺1,82K

Veriler Yükleniyor

Grafik verilerini yüklüyoruz, lütfen bekleyin

Novo Nordisk A/S topluluğu

skeleton-white
 
 
 
 
 
 

About Novo Nordisk A/S

What is Novo Nordisk A/S?

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S Fiyatı Canlı Veri

The current price of Novo Nordisk A/S in the market is ₺1.828,29, with a 24-hour trading volume of ₺33,79B. The asset's market cap is ₺8,1T, after moving 0.13% in the last day.

Tokenized Novo Nordisk A/S is trading at ₺1.822,11, with a tokenized market cap of ₺148,09M and a 24-hour trading volume of ₺37,92M. The tokenized asset has moved 3.80% in the past 24 hours.